BCNA joins Advisory Group to shape generational reform in health technology assessment
20 Nov 2024
Breast Cancer Network Australia (BCNA) is proud to have its Chief Executive Officer, Kirsten Pilatti, appointed as a member of this influential group.
This appointment is a culmination of BCNA’s decades-long advocacy for a health technology assessment process that is transparent, equitable, and inclusive. As a member of the IAG, BCNA feels privileged to have a seat at the table, and it is committed to ensuring that the voices of all Australians are reflected in these reforms, which aim to reshape healthcare for generations to come.
The IAG will guide the implementation of recommendations from the HTA Review Report, released in September. These recommendations focus on improving access to new technologies, ensuring equity, and simplifying processes for consumers and clinicians. The report also highlights the need to reduce delays in funding medicines and futureproof the HTA system to address emerging challenges.
Health technology assessment evaluates the quality, safety, efficacy, and value for money of new health technologies before they are subsidised by the government. These reforms aim to ensure all Australians have timely access to life-saving and innovative treatments.
